Rational Use of Intensity-Modulated Radiation Therapy: The Importance of Clinical Outcome (Q37969372)

26 August 2017

title

Rational use of intensity-modulated radiation therapy: the importance of clinical outcome (English)

1 reference

26 August 2017

Rational Use of Intensity-Modulated Radiation Therapy: The Importance of Clinical Outcome (English)

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

adaptive radiation therapy

20 December 2024

main subject

0 references

author name string

Wilfried De Neve

1

1 reference

26 August 2017

Werner De Gersem

2

1 reference

26 August 2017

Indira Madani

3

1 reference

26 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22177877

20 December 2024

publication date

1 January 2012

1 reference

26 August 2017

January 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22177877

full work available at URL

20 December 2024

https://api.elsevier.com/content/article/PII:S1053429611000944?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

https://api.elsevier.com/content/article/PII:S1053429611000944?httpAccept=text/plain

20 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Seminars in Radiation Oncology

20 December 2024

published in

1 reference

26 August 2017

volume

22

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

40-49

1 reference

Solution of an integral equation encountered in rotation therapy.

26 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Rotation therapy using a novel high-gradient filter

20 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Photon beam energy deposition kernels for inverse radiotherapy planning.

20 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Initial clinical experience with the Peacock intensity modulation of a 3-D conformal radiation therapy system

20 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity-modulated radiation therapy: the inverse, the converse, and the perverse

20 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies

20 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

20 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.

20 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

20 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

20 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

20 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies

20 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Accelerated Partial Breast Irradiation With IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial

20 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin

20 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma

20 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Comparison of otologic complications between intensity‐modulated and two‐dimensional radiotherapies in nasopharyngeal carcinoma patients

20 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

20 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer

20 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy

20 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer

20 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

20 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy

20 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life

20 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

20 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation

20 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Phase I–II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients

20 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis

20 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy

20 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity-Modulated Radiotherapy Reduces Gastrointestinal Toxicity in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer

20 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Late toxicity after conformal and intensity-modulated radiation therapy for prostate cancer: impact of previous surgery for benign prostatic hyperplasia

20 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer

20 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy

20 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

20 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.

20 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

20 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy

20 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer

20 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal

20 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer

20 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma

20 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers

20 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Hypoxia dose painting by numbers: a planning study.

20 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Adaptive dose painting by numbers for head-and-neck cancer

20 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

20 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Theragnostic imaging for radiation oncology: dose-painting by numbers

20 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

Intensity modulating and other radiation therapy devices for dose painting

20 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SEMRADONC.2011.09.003

20 December 2024

Identifiers

1 reference

26 August 2017

1 reference